JP2023530072A5 - - Google Patents
Info
- Publication number
- JP2023530072A5 JP2023530072A5 JP2022570473A JP2022570473A JP2023530072A5 JP 2023530072 A5 JP2023530072 A5 JP 2023530072A5 JP 2022570473 A JP2022570473 A JP 2022570473A JP 2022570473 A JP2022570473 A JP 2022570473A JP 2023530072 A5 JP2023530072 A5 JP 2023530072A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063041643P | 2020-06-19 | 2020-06-19 | |
| US202063041474P | 2020-06-19 | 2020-06-19 | |
| US63/041,474 | 2020-06-19 | ||
| US63/041,643 | 2020-06-19 | ||
| PCT/US2021/038126 WO2021258011A1 (en) | 2020-06-19 | 2021-06-18 | Compounds and methods for modulating pmp22 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023530072A JP2023530072A (ja) | 2023-07-13 |
| JP2023530072A5 true JP2023530072A5 (https=) | 2024-06-24 |
| JPWO2021258011A5 JPWO2021258011A5 (https=) | 2024-06-24 |
Family
ID=79025354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022570473A Pending JP2023530072A (ja) | 2020-06-19 | 2021-06-18 | Ｐｍｐ２２を調節するための化合物及び方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230374519A1 (https=) |
| EP (1) | EP4168549A4 (https=) |
| JP (1) | JP2023530072A (https=) |
| WO (1) | WO2021258011A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017229778A1 (en) | 2016-03-09 | 2018-08-16 | Ionis Pharmaceuticals, Inc. | Methods and compositions for inhibiting PMP22 expression |
| WO2025150052A1 (en) * | 2024-01-12 | 2025-07-17 | Potentia Ltd. | Targeted delivery of drug conjugates to schwann cells and treatment methods in schwann cell-related diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101869570B1 (ko) * | 2010-04-28 | 2018-06-20 | 아이오니스 파마수티컬즈, 인코포레이티드 | 변형된 뉴클레오사이드 및 그로부터 제조된 올리고머 화합물 |
| EP3286318A2 (en) * | 2015-04-22 | 2018-02-28 | Mina Therapeutics Limited | Sarna compositions and methods of use |
| AU2017229778A1 (en) * | 2016-03-09 | 2018-08-16 | Ionis Pharmaceuticals, Inc. | Methods and compositions for inhibiting PMP22 expression |
| AU2019218987B2 (en) * | 2018-02-12 | 2025-04-24 | Ionis Pharmaceuticals, Inc. | Modified compounds and uses thereof |
| EP3628735A1 (en) * | 2018-09-25 | 2020-04-01 | Centre National De La Recherche Scientifique | Antisense rna targeting pmp22 for the treatment of charcot-marie-tooth 1a disease |
| WO2020132558A1 (en) * | 2018-12-21 | 2020-06-25 | Ionis Pharmaceuticals, Inc. | Compounds and methods for reducing pmp22 expression |
| JP2023501352A (ja) * | 2019-11-08 | 2023-01-18 | アイオーニス ファーマシューティカルズ， インコーポレーテッド | Ｓｐｄｅｆ発現を低減するための化合物及び方法 |
-
2021
- 2021-06-18 EP EP21825416.7A patent/EP4168549A4/en active Pending
- 2021-06-18 JP JP2022570473A patent/JP2023530072A/ja active Pending
- 2021-06-18 WO PCT/US2021/038126 patent/WO2021258011A1/en not_active Ceased
- 2021-06-18 US US18/001,848 patent/US20230374519A1/en active Pending